Navigation Links
Covance Elects Joseph C. Scodari to Company's Board of Directors
Date:5/8/2008

PRINCETON, N.J., May 8 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD) today announced that it has elected Joseph C. Scodari to its Board of Directors.

"We are very pleased to have Joe Scodari join our Board of Directors. He has enjoyed a distinguished 34-year career as a key leader in the pharmaceutical and biotechnology industries, and he has a proven track record of driving growth in large, complex global healthcare businesses," said Joe Herring, Covance chairman and CEO. "In addition, Mr. Scodari's expertise in strategy development and pharmaceutical R&D will help us further strengthen our large client partnerships and enhance our ability to provide productivity solutions that matter."

"Covance's market leadership and broad service offerings position it well to help pharmaceutical companies reduce the time and cost of drug development," Mr. Scodari said. "I look forward to working with Joe and the esteemed group of board members to take advantage of the significant market opportunities in the drug development services industry and continue to drive the company's growth."

Mr. Scodari was recently the worldwide chairman of the Johnson & Johnson (J&J) Pharmaceuticals Group. In this role, he led efforts to improve research and development productivity and build a more robust pipeline. He was also a member of the J&J executive committee and a corporate officer. Before Mr. Scodari was appointed worldwide chairman of J&J's pharmaceutical business in 2005, he was the company group chairman of J&J's global biopharmaceuticals business and was responsible for commercial activities in biotechnology and for specialty businesses in oncology and virology. Under his leadership, Tibotec Therapeutics launched PREZISTA(R) (darunavir), the company's first entry into the HIV market. Previously, Mr. Scodari served as company group chairman for the North America pharmaceuticals business, which included management responsibility for Ortho-McNeil, Janssen Pharmaceutica, and Janssen-Ortho Inc., Canada. Prior to these roles, he served as president and COO, and as a director of Centocor, Inc. and led the organization's transformation from a focus on research and development to a fully integrated biopharmaceutical company. Mr. Scodari has also held leadership positions in Rhone-Poulenc Rorer Pharmaceuticals and Sterling Drug, Inc.

Mr. Scodari recently served as the vice chairman of the board and member of the executive committee of the Biotechnology Industry Organization (BIO). He has also served on the Board of Overseers of the Robert Wood Johnson School of Medicine and on the Board of Trustees of The University of the Sciences in Philadelphia. He was also previously a member of the Board of Directors of Pharmacyclics, Inc., a biopharmaceutical company focused on therapies for cancer. He has a B.A. from Youngstown State University.

Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with annual revenues greater than $1.5 billion, global operations in more than 20 countries, and more than 8,900 employees worldwide. Information on Covance's products and services, recent press releases, and SEC filings can be obtained through its website at http://www.covance.com.


'/>"/>
SOURCE Covance Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Covance to Present at the UBS Global Life Sciences Conference
2. Covance Elects Dr. Gary E. Costley to Board of Directors
3. Covance Agrees to Enter Strategic Relationship with eResearchTechnology to Offer its Clients eRTs Centralized Cardiac Safety Services
4. eResearchTechnology (eRT) Agrees to Acquire the Centralized ECG Business of Covance
5. eResearchTechnology, Inc. to Announce Agreement to Acquire the Centralized ECG Business of Covance
6. Covance and Care Partner on Rwanda Early Childhood Development Initiative
7. Wendel Barr Appointed Chief Operating Officer of Covance
8. Covance to Present at 26th Annual JPMorgan Healthcare Conference
9. Covance to Present at UBS Global Healthcare Services Conference
10. Covance to Present at Raymond James 29th Annual Institutional Investors Conference
11. Covance to Present at Lehman Brothers 11th Annual Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Apple ... care services, staged a mock evacuation of the facility as part of a disaster ... Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well as the ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Global Healthcare Management’s ... Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s ... The fun run is geared towards children of all ages; it is a ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest and ... plans to open a flagship location in Covington, LA at 401 N. U.S. Highway ... store next to Office Depot in the Holiday Square shopping center. Its location allows ...
(Date:10/12/2017)... ... 2017 , ... Asante, a nationally recognized health system in ... existing home health joint venture through an agreement, effective October 1, 2017, to ... home health company with Asante, delivering clinically integrated care, for the past eight ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... -- NDS received FDA 510(k) clearance in May 2017 for its highly ... designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... support the improvement of patient outcomes, procedural efficiency, and the lowering ... ... ...
(Date:10/4/2017)... 4, 2017  South Korean-based healthcare product Development Company ... "cprCUBE" on Kickstarter. The device will educate the user ... with better efficiency compared to the dated and pricey ... on efficacy of the compression for a more informed ... goal to raise $5,000. ...
(Date:10/2/2017)... 2017  Eli Lilly and Company (NYSE: ... third quarter of 2017 on Tuesday, October 24, 2017. ... day with the investment community and media to further ... call will begin at 9 a.m. Eastern time. Investors, ... webcast of the conference call through a link that ...
Breaking Medicine Technology: